AKT1 and familial pancreatic carcinoma: PI3K-Akt signaling pathway is abnormally activated in pancreatic cancer, affecting multiple biological processes such as cancer cell cycle progression and cellular metabolic rate, and associated with poor prognosis of patients (69–71).